This article has been updated to clarify that a team from Broad Institute and its collaborators originally discovered Cas13a in October 2015.
NEW YORK (GenomeWeb) – A team of University of California, Berkeley researchers led by Jennifer Doudna have published a study describing variants of the Cas13a CRISPR protein that could be used to diagnose disease.